tiprankstipranks
Trending News
More News >
Mural Oncology Plc (MURA)
NASDAQ:MURA
US Market

Mural Oncology Plc (MURA) Income Statement

Compare
418 Followers

Mural Oncology Plc Income Statement

Last quarter (Q3 2025), Mural Oncology Plc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Mural Oncology Plc's net income was $-3.71M. See Mural Oncology Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.51M$ -2.57M$ 0.00$ -1.47M
Operating Expenses
$ 134.75M$ 192.07M$ 184.92M$ 173.89M
Depreciation and Amortization
$ 3.51M$ 2.57M$ 1.54M$ 1.47M
EBITDA
$ -125.00M$ -192.72M$ -183.38M$ -173.89M
Operating Income
$ -138.26M$ -194.64M$ -184.92M$ -175.37M
Other Income/Expenses
$ 9.75M$ -649.00K$ 0.00$ 0.00
Pretax Income
$ -128.51M$ -195.29M$ -184.92M$ -175.37M
Net Income
$ -128.51M$ -207.45M$ -189.81M$ -175.43M
Per Share Metrics
Basic EPS
$ -7.58$ -12.43$ -11.37$ -10.51
Diluted EPS
$ -7.58$ -12.43$ -11.37$ -10.51
Weighted Average Shares Outstanding
16.95M 16.69M 16.69M 16.69M
Weighted Average Shares Outstanding (Diluted)
16.95M 16.69M 16.69M 16.69M
Currency in USD

Mural Oncology Plc Earnings and Revenue History